share_log

Piper Sandler Initiates Coverage On Agios Pharmaceuticals With Overweight Rating, Announces Price Target of $41

Benzinga Real-time News ·  Feb 3, 2023 05:03

Piper Sandler analyst Christopher Raymond initiates coverage on Agios Pharmaceuticals (NASDAQ:AGIO) with a Overweight rating and announces Price Target of $41.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment